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Edited by Sandro SonninoAbstract Palmitoylcarnitine was previously shown to promote
diﬀerentiation of neuroblastoma NB-2a cells. It was also ob-
served to increase palmitoylation of several proteins and to
diminish incorporation of palmitic acid to phospholipids, as well
as to aﬀect growth associated protein GAP-43 by decreasing its
phosphorylation and interaction with protein kinase C. The
present study was focused on inﬂuence of palmitoylcarnitine on
palmitoylation of GAP-43 and lipid metabolism. Althought
palmitoylcarnitine did not signiﬁcantly aﬀect the total phospho-
lipids and fatty acid content, it increased incorporation of palm-
itate moiety to triacylglicerides and cholesterol esters, with a
decrease of free cholesterol content. The presence of palmitoyl-
carnitine signiﬁcantly increased the amount of covalently bound
palmitate to GAP-43, which can regulate the signal transduction
pathways.
 2007 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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Palmitoylcarnitine is synthesized in the cell from palmitoyl-
CoA and L-carnitine by carnitine palmitoyltransferase I
(CPT1) localized in the outer mitochondrial membrane and
is further transported to mitochondrial matrix to deliver acyl
moieties to mitochondria for their b-oxidation [1]. Palmitoyl-
carnitine was also shown to be an acyl moiety donor for
several phospholipids [2,3] and to regulate activity of some
proteins, including caspases [4], protein Gi [5] and protein
kinase C (PKC) [6–9]. Most probably, as a consequence of
its interaction with proteins important in signaling cascade,
palmitoylcarnitine was observed to stimulate diﬀerentiation
and to inhibit proliferation of transformed cells [6,10].Abbreviations: BSA, bovine serum albumin; BSTFA, N,O-bis-(tri-
methylsilil)-triﬂuoroacetamide; CPT1, carnitine palmitoyltransferase I;
FID, ﬂame ionization detection; PBS, phosphate buﬀered saline; PKC,
protein kinase C; PVDF, polivinylidene diﬂuoride; SDS, sodium
dodecyl sulfate; TMCS, trimethylchlorosilane
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doi:10.1016/j.febslet.2007.07.027One of the proteins, the expression of which is up-regulated
in diﬀerentiating neural cells [11], is GAP-43, a protein known
to regulate G0 activity, as well as to bind calmodulin [12,13].
Palmitoylcarnitine was shown to inhibit GAP-43 interaction
with PKC and its phosphorylation [8,14] and to promote its
transfer to membrane fraction [14]. GAP-43 is known to be
palmitoylated at Cys3 and Cys4 [15]. Since palmitoylcarnitine
was shown to stimulate incorporation of radioactive palmitate
to several proteins, as well as to promote co-localization of
GAP-43 with caveolin-1 [3], a protein typical for cholesterol-
rich microdomains [16], we investigated the possible eﬀect of
palmitoylcarnitine on palmitoylation of GAP-43 and choles-
terol content.2. Materials and methods
2.1. Materials
Palmitic acid [9,10-3H] was from American Radiolabeled Chemicals
(St. Louis, MO), [1-14C]palmitic acid was from Schwartz/MANN
(Orangenburg, New York). Palmitoylcarnitine chloride, cholesterol,
cholesterol esters, dipalmitoylglycerol, cholesterol oxidase, 3-(cyclo-
hexylamino)-1-propane sulfonic acid, protease inhibitors, mousemono-
clonal anti-GAP-43 (clone GAP-7B10) antibody were from Sigma
(Poznan´, Poland). Protein A Sepharose CL-4B, Amplify, Hyperﬁlm
TM-MP, HybondECL nitrocellulose membrane and ECLKit were
purchased from Amersham (Bucks, UK). Components of cell culture
were from Invitrogen (Paisley,UK), tissue culture plastics fromCorning
Inc. (New York, USA). Thin layer chromatography silica gel 60
aluminium sheets and 6,6 0-dihydroxy-3,3 0-diphenylacetate were from
Merck (Warszawa, Poland). Immobilon polivinylidene diﬂuoride
(PVDF) membrane was from Millipore (Warszawa, Poland). N,O-Bis-
(trimethylsilil)-triﬂuoroacetamide (BSTFA) and trimethylchlorosilane
(TMCS) were from Pierce (Rockford, USA). BF3 was from Supelco
(Sigma–Aldrich group). All other reagents were of analytical grade.
2.2. Cell culture
Neuroblastoma NB-2a cells were grown as previously described [3].
Incubation with either palmitoylcarnitine coupled to bovine serum
albumin (BSA) or BSA alone were performed as given in [6].
2.3. Analysis of GAP-43 palmitoylation
The NB-2a cells were washed twice with 0.005% BSA in phosphate
buﬀered saline (PBS) and collected in PBS with 5 mM glucose. Incuba-
tion with 3.4 lM [3H]palmitic acid (60 Ci/mmol) was performed for 1 h
either in the absence or presence of 100 lM palmitoylcarnitine
(1.4 · 107 cells per experimental system). Homogenization was per-
formed in 150 mM NaCl, 1% Triton X-100, 50 mM Tris–HCl, pH
7.4 supplemented with protease inhibitors, as described in [3]. Protein
content was estimated and the samples containing the same amount of
protein (4 mg/ml) were subjected to preclearance and immunoprecipi-
tation with anti-GAP-43 antibodies according to [8]. Proteins elutedblished by Elsevier B.V. All rights reserved.
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tion of palmitoylation was performed either by cutting the gels into
slices or by electrotransfer of separated proteins to Immobilon
PVDF membrane in 10 mM 3-(cyclohexylamino)-1-propane sulfonic
acid, 10% methanol, pH 11 at 400 mA for 1 h. The parallel samples
were treated either with methanol or 0.2 M KOH in methanol and
palmitoylation was quantiﬁed from the calculated diﬀerence in radio-
activity [3]. For autoradiography the membranes were washed with
water, dried, treated for 20 min with Amplify reagent and exposed to
the preﬂashed ﬁlm against intensifying screen for 4–8 weeks at 80 C.
2.4. Lipid analysis
Lipids were extracted with methanol/chloroform [3]. For analysis of
fatty acids chloroform phase was evaporated under nitrogen, followed
by saponiﬁcation in 0.5 M KOH in methanol for 10 min at 80 C. Free
fatty acids were estriﬁed with 12% BF3 in methanol at 80 C, the
methyl esters were extracted with hexan, precipitated with saturated
NaCl and dried with Na2SO4. Separation was performed with gas
chromatograph (Agilent Technologies, model 6890N) with ﬂame ioni-
zation detection system (FID) and helium, hydrogen and air as the
detector gases. An SGE column BPX70 of 60 m · 0.22 mm and
0.25 lm phase thickness was used with helium 250 kPa as carrier
gas. Sample of 1 ll was injected at 220 C (split 100:1), the column
temperature was programmed as follows: 1 min at 140 C, increase
1.5 C/min to 210 C, 5 min at 210 C, detector temperature 250 C.
The identity of fatty acids and their relative content was estimated
from the retention times of known certiﬁed materials: CRM 162
Soya–maize oil, CRM 163 Beef–pork fat, CRM 164 Anhydrous milk
fat. For estimation of total cholesterol one of parallel samples contain-
ing 7.5 mg cell protein was supplemented with 0.5 mg of 5a-cholestan
as internal standard, further steps till extraction and drying were per-
formed as described above. Dry samples were supplemented with 50 ll
BSTFA containing 1% TMCS and with 50 ll piridin and incubated for
20 min at 80 C, cooled and diluted with hexan to 0.5 ml. Analysis was
performed with J&W Scientiﬁc column HP-1 (25 m · 0.20 mm, phase
thickness 0.11 lm) with helium 100 kPa as carrier gas. Sample was in-
jected at 290 C (split 25:1) and the temperature was programmed in
the following way: 4 min at 250 C, increase 5 C/min to 300 C,
8 min at 300 C, detector temperature 300 C. Cholesterol quantiﬁca-
tion was performed by integration of peak area. For estimation of free
cholesterol the cellular pellet was suspended in isopropanol and
homogenized by passing through 25 G needle. Free cholesterol was as-
sayed enzymatically with cholesterol oxidase and 6,6 0-dihydroxy-3,30-
diphenylacetate according to [17] with use of Fluorog 2 SPEX ﬂuorim-0
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Fig. 1. Relative content of fatty acids in NB-2a cells. The cells were grown w
bars), 3.4 lM palmitic acid (cyan bars) or both palmitic acid and palmito
separated by gas chromatography. The results present means ± S.E.M. frometer at 325 nm and 415 nm for excitation and emission, respectively.
Incorporation of palmitate to cholesterol esters and triacylglycerols
was estimated after separation of lipid extract by thin layer chromatog-
raphy in hexan–diethylether–acetic acid 80:20:1 (v/v) [18].2.5. Miscellaneous techniques
Amount of phospholipids was estimated from the content of phos-
phorus [19] after mineralization of extracted lipids in 70% HClO4 at
180 C. Oxidation of 3.4 lM [14C]palmitic acid (49.2 mCi/mmol) was
measured by incubation of cells for 1 h at 37 C in sealed tubes
equipped with hanging propylene cups containing a strip of Whatman
3MM ﬁlter paper soaked with 100 ll of 2-phenylethylamine [20]. The
reaction was terminated by injection of 1 M perchloric acid, followed
by 30 min incubation at 37 C and counting of ﬁlter papers radioac-
tivity.3. Results
Experiments on protein palmitoylation demand administra-
tion of radioactive palmitate, therefore its metabolism was
analysed in more detail. Process of b-oxidation was very low
in NB-2a cells, it did not exceed 5.6 ± 1.1% of total accumula-
tion in control cells and 7.5 ± 0.3% in the presence of palmi-
toylcarnitine. The amount of added palmitate moiety did not
change signiﬁcantly the measured distribution of fatty acids
(Fig. 1). Oleic acid (18:1c9) was the most abundant one in
NB-2a cells, although the relative content of palmitic acid
(16:0) was also very high. It is worth mentioning that stearic
(18:0) and 11-octadecenoic (18:1c11) acids were also present
in substantial amount. Addition of palmitoylcarnitine did
not change the content of phospholipids, being 30.86 ±
10.01 nmol/mg protein under control conditions and
29.36 ± 11.07 nmol/mg protein in the presence of palmitoylcar-
nitine. Due to the fact that radioactive palmitic acid was
previously shown to accumulate in lipid fraction, the incorpo-
ration of palmitic moiety in lipid esters was estimated. As
shown in Fig. 2, palmitic acid estriﬁed several lipids, addition20
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three independent experiments.
3952 K.A. Nałe˛cz et al. / FEBS Letters 581 (2007) 3950–3954of palmitoylcarnitine decreased its incorporation in dipalmi-
toylglycerol with a signiﬁcant (three- to fourfold) increase in
tripalmitoylglycerol and cholesterol esters (Fig. 2B). This
increase resulted from preferential estriﬁcation, since total
amount of cholesterol did not change in the presence of palm-
itoylcarnitine, while the amount of free cholesterol decreased
signiﬁcantly (Table 1).0.0 0.1 0.2 0.3
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Fig. 2. Eﬀect of palmitoylcarnitine on estriﬁcation of cholesterol. NB-2a cell
or with 3.4 lM [9,10-3H] palmitic acid and 100 lM palmitoylcarnitine
chromatography. Position of the following lipid standards has been indi
cholesterol; AcCh, cholesterol acetate; MCh, cholesterol myristate; PCh, chole
relative labeling of separated lipids, the lower panel shows the same data expr
results obtained without palmitoylcarnitine. Insets show the corresponding rAn increase of palmitoylcarnitine content in neuroblastoma
NB-2a cells was shown to augment amount of GAP-43 protein
localized in the membrane fraction [14] and its co-localization
with caveolin-1 [3], a protein known to be present in choles-
terol-rich domains of plasma membrane containing many
palmitoylated proteins. Taking into account an increased pro-
tein palmitoylation in the presence of palmitoylcarnitine [3],0.4 0.5 0.6 0.7
f
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s were incubated either with 3.4 lM [9,10-3H] palmitic acid (ﬁlled bars)
(open bars) and the extracted lipids were subjected to thin layer
cated: DPG, dipalmitoylglycerol; TPG, tripalmitoylglycerol; CHOL,
sterol palmitate, OlCh, cholesterol oleate. The upper panel presents the
essed as a relative change in each particular lipid when compared to the
esults analysed at Rf 0.6–0.9.
Table 1
Cholesterol content in NB-2a cells
Cholesterol
Total Free
(nmol/mg protein) % (nmol/mg protein) %
Control
+ Palmitoylcarnitine
84.3 ± 8.1 (3) 100 69.7* ± 14.8 (18) 83
87.5 ± 5.8 (3) 104 46.4* ± 2.4 (18) 55
NB-2a cells were incubated either with BSA (control) or with BSA and 100 lM palmitoylcarnitine. Total cholesterol was estimated after extraction
by gas chromatography, free cholesterol by enzymatic reaction with 6,6 0-dihydroxy-3,30-diphenylacetate and ﬂuorescence measurement. Number of
independent measurements is indicated in parentheses.
*P < 0.05 against control.
Fig. 3. Binding of [3H]palmitic acid to GAP-43 protein. NB-2a cells were incubated with [9,10-3H]palmitic acid without palmitoylcarnitine (lanes a
and c) or upon addition of 100 lM palmitoylcarnitine (lanes b and d). The protein extract was subjected to immunoprecipitation with anti-GAP-43
antibodies and electrophoresis (A), gel after immunoprecipitation before quantitative estimation of palmitoylation. (B) Autoradiograph after
electrotransfer. Part of the PVDF membrane (lanes a and b) was treated with methanol, whilst the other part (lanes c and d) with KOH in methanol.
The image shows a representative autoradiograph after exposure for 5 weeks. (C) Western blot of protein extract (200 lg) demonstrating migration
of GAP-43.
K.A. Nałe˛cz et al. / FEBS Letters 581 (2007) 3950–3954 3953and detected decrease of free cholesterol, the further studies
were focused on GAP-43 palmitoylation and possible regula-
tion by palmitoylcarnitine. As shown in Fig. 3B (lanes a and
b) the radioactive palmitate moiety is bound to proteins immu-
noprecipitated with anti-GAP-43 antibodies, out of which the
band migrating with Mr of 43000 corresponds to GAP-43
(Fig. 3C) and the others result from co-precipitation. The
observed diﬀerences did not result from various eﬃciency of
immunoprecipitation, since the same amount of protein was
detected in Coomassie stained lanes (Fig. 3A). In three consec-
utively prepared autoradiographs a quantitative estimation of
band intensities in the control and palmitoylcarnitine treated
samples revealed no diﬀerences in the total palmitate binding
when referred to the corresponding controls (98 ± 5.6%). The
intensity of the bands in KOH treated part of the membrane
decreased to diﬀerent degree in diﬀerent bands (Fig. 3B, lanes
c and d), the lowest band disappeared completely. In case of
bands with Mr = 43000 and 41000, in the control samples
the intensity was diminished by 56 ± 3.3%, whilst in the sam-
ples incubated with palmitoylcarnitine the decrease of intensity
reached 85 ± 2%, which indicated an increase in palmitoyla-
tion status of both proteins. Palmitate binding which was
not hydrolyzed by KOH could result from formation of oxy-
esters or non-covalent binding, especially that GAP-43 is
known not to be fully denatured by sodium dodecyl sulfate(SDS). The quantitative data were obtained after measure-
ments of radioactivity in gel slices (shown in Fig. 3A) and
in case of GAP-43 an 80% increase of palmitoylation was
detected, i.e. from 0.15 ± 0.04 to 0.27 ± 0.05 fmole of palmitate
per 1 mg of total protein taken for immunoprecipitation.4. Discussion
[3H]Palmitic acid is incorporated into several lipids and pro-
teins in NB-2a cells [3], its b-oxidation is very low, which is in
agreement with high glycolytic activity of transformed cells
[21]. Also the high content of oleic acid (18:1c9) resembles
other transformed cells [22]. Addition of palmitoylcarnitine re-
sults in an increased incorporation of [3H]palmitic acid to tri-
acylglycerol, cholesterol esters and to proteins during their
palmitoylation. Since the total amount of either fatty acids
and phospholipids did not change upon addition of palmitoyl-
carnitine, the observed diﬀerences in [3H]palmitate incorpora-
tion could result from preferential incorporation of palmitate
moiety from palmitic acid after its activation to palmitoyl-
CoA.
Palmitoylcarnitine decreased the amount of free cholesterol
by its estriﬁcation. It is postulated that free cholesterol is pres-
ent in the rafts and caveolae, i.e. in cholesterol-rich domains.
3954 K.A. Nałe˛cz et al. / FEBS Letters 581 (2007) 3950–3954Extraction of cholesterol destroys such domains, aﬀecting the
interaction between proteins localized within these domains,
such experiments do not consider another regulatory factor,
i.e. palmitoylation of proteins. Palmitoylcarnitine was shown
to increase palmitoylation of several proteins [3] and the pres-
ent study demonstrates an increased palmitoylation of GAP-
43. Palmitoylcarnitine was also shown to promote co-localiza-
tion of GAP-43 with caveolin-1 [3], apart from a decrease of
free cholesterol, indicating that palmitoylation alone could
be suﬃcient for localization in certain domains of plasma
membrane. It should be added, that at least in case of certain
proteins, interaction with caveolin-1 was proposed to attenuate
their signaling activity [23]. In case of GAP-43 interacting with
many proteins, including G0 [12], calmodulin [13] and PKCd
[24], co-localization with caveolin-1 could aﬀect the down-
stream pathways, especially since we observed decreased phos-
phorylation of GAP-43 [14] and inhibited interaction with
PKCd [8] upon accumulation of palmitoylcarnitine.References
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